SEC Filing Summary: AlloVir, Inc. (ALVR)
Business Context and Reporting Period
This Form 8-K Current Report, dated May 11, 2023, covers the 2023 Annual Meeting of Stockholders held by AlloVir, Inc. The filing details the ratification of corporate governance matters and a significant amendment to the company's charter. Note: The request metadata references "Kalaris Therapeutics, Inc.," but the filing text explicitly identifies the registrant as "AlloVir, Inc."
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure changes.
Material Changes
- Authorized Share Increase: Stockholders approved an amendment to the Certificate of Incorporation to increase authorized common stock from 150,000,000 to 300,000,000 shares. The amendment was filed with the Delaware Secretary of State on May 15, 2023, and became effective immediately.
- Board of Directors Election: Stockholders elected four Class III directors (Jeffrey Bornstein, Diana Brainard, M.D., David Hallal, and Shawn Tomasello) to serve until the 2026 Annual Meeting.
- Independent Auditor Ratification: Stockholders ratified the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding business outlook, financial guidance, or specific risk factors. The document is a procedural report of shareholder voting results and charter amendments.
Investor Verification Checklist
- Verify the effective date of the Charter Amendment (May 15, 2023) and the new authorized share count (300,000,000).
- Confirm the tenure of the newly elected Class III directors (through the 2026 Annual Meeting).
- Review the Definitive Proxy Statement filed on March 31, 2023, for detailed background on the proposals.
- Note the significant number of Broker Non-Votes (24,044,016) recorded for the director elections, indicating shares held in street name where brokers lacked discretionary voting power.